UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: The herb ginger may help to reduce or prevent nausea and vomiting in patients receiving chemotherapy for cancer. PURPOSE: This randomized phase II trial is studying how well ginger works in reducing or preventing nausea and vomiting in patients who are receiving chemotherapy for cancer.

Key facts

Study ID

NCT00064272

Run by

University of Michigan Rogel Cancer Center

People needed

180

Starts

2003-05-01

Last updated by the study team

2016-10-21

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
• University of Michigan Cancer Center CCOP Research Base — Ann Arbor, Michigan, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• CCOP - Grand Rapids — Grand Rapids, Michigan, United States
• MBCCOP - Our Lady of Mercy Cancer Center — The Bronx, New York, United States
• MBCCOP - San Juan — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.